GENERALIZED MYASTHENIA GRAVIS (GMG)
Clinical trials for GENERALIZED MYASTHENIA GRAVIS (GMG) explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS (GMG) trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS (GMG), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for MG patients: study tests safer drug combos
Disease control Recruiting nowThis study is testing different drug combinations to find safer and more effective treatments for people with myasthenia gravis, a condition that causes muscle weakness. About 70 adults with generalized MG will try either a new drug alone or added to their current treatment. The …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Sponsor: argenx • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug aims to shorten hospital stays for MG patients
Disease control Recruiting nowThis study tests a daily injection called zilucoplan in 15 adults hospitalized with severe generalized myasthenia gravis (gMG). The goal is to see if the drug can quickly improve muscle weakness and daily activities within 2 weeks. Participants receive the treatment for 12 weeks,…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Phase: PHASE3 • Sponsor: Miriam Freimer • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New cell therapy trial hopes to tame Hard-to-Treat muscle weakness
Disease control Recruiting nowThis early study tests an experimental treatment called GC012F for people with refractory generalized myasthenia gravis, a condition causing severe muscle weakness. Six participants will receive the injection to see if it is safe and shows signs of helping control the disease. Th…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New drug combo aims to ease severe muscle weakness
Disease control Recruiting nowThis study tests whether adding empasiprubart to the standard treatment efgartigimod can further improve symptoms in people with a specific type of generalized myasthenia gravis (gMG). About 70 adults who still have partial symptoms despite efgartigimod will receive the combinati…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Russian study tracks Real-Life MG care without new drugs
Knowledge-focused Recruiting nowThis study looks at how doctors in Russia currently treat a rare muscle-weakening disease called generalized myasthenia gravis (gMG). Researchers will collect medical records and follow about 450 adults with the AChR-antibody form of the disease to see which treatments are used a…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 00:46 UTC
-
New study monitors ultomiris safety for pregnant women and their babies
Knowledge-focused Recruiting nowThis study looks at the safety of the drug Ultomiris when used during pregnancy. Researchers will track 75 pregnant or postpartum women who take Ultomiris for conditions like PNH or aHUS. They will record pregnancy complications, maternal health issues, and infant health outcomes…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS (GMG)
Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC